Truecaller SDK breaks new ground with over 7 billion+ sign-up requests
NV
3 min read
53

Truecaller SDK breaks new ground with over 7 billion+ sign-up requests

November 6, 2024
0

Reading Time: 2 minutes Truecaller continues to redefine mobile-first technology through its groundbreaking Truecaller SDK, the industry’s leading solution for phone number-based seamless user verification. The solution is based on industry-standard OAuth 2.0 and eliminates the hassle of generating OTP through SMS and alternative verification channels.  

Continue Reading
CSP
3 min read
52

Navamedic launches Eroxon[®] in Finland

November 6, 2024
0

Reading Time: 2 minutes Oslo, 6 November 2024 – Building on the successful product launch of Eroxon® in Norway and Sweden earlier this year, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, is now launching Eroxon®

Continue Reading
Nasik, Nagpur, Coimbatore Lead Tier-2 City Growth, Buoyed by Staffing, BFSI, and IT Services: foundit
BWI
7 min read
34

Nasik, Nagpur, Coimbatore Lead Tier-2 City Growth, Buoyed by Staffing, BFSI, and IT Services: foundit

November 6, 2024
0

Reading Time: 6 minutes   Bengaluru, Karnataka, India:  A new report on job hiring trends from foundit (formerly Monster APAC & ME), Asia’s leading jobs and talent platform, reveals that India’s Tier-2 cities have experienced steady growth over the past few years, with overall hiring increasing

Continue Reading
CSP
2 min read
52

Two thousand square meters let at Kaserntorget 6

November 6, 2024
0

Reading Time: 2 minutes Wallenstam’s initiative involving reuse, green leases and full-service offices ready for occupation at Kaserntorget 6 has been highly sought after. Recently, Prodesign signed an agreement for the last premises of 460 square meters and will move in during January next year. This

Continue Reading
An Unforgettable Night of Sufi Magic
NV
4 min read
52

An Unforgettable Night of Sufi Magic

November 6, 2024
0

Reading Time: 3 minutes iluzn Club & Kitchen, Gurugram’s premier destination for immersive nightlife, is thrilled to announce “Bismil Ki Mehfil,” an unforgettable night featuring the one and only Bismil, on Saturday, 9th November, from 10:30 PM onwards. The event serves as an exclusive afterparty for Bismil’s highly successful

Continue Reading
BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024
BWI
14 min read
34

BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024

November 6, 2024
0

Reading Time: 11 minutes San Mateo, Calif., United States:   Five-year results of Phase 3 SEQUOIA study demonstrate durable benefits of BRUKINSA in patients with CLL Two oral presentations showcase promising safety and efficacy data for BTK chimeric degradation activation compound (CDAC), BGB-16673 Oral presentation highlights

Continue Reading
Burjeel Holdings and Response Plus Medical launch mn Human Energy Health and Wellbeing Award
BWI
3 min read
36

Burjeel Holdings and Response Plus Medical launch $1mn Human Energy Health and Wellbeing Award

November 6, 2024
0

Reading Time: 3 minutes Abu Dhabi, United Arab Emirates:   Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region, and Response Plus Medical Services (RPM), the largest pre-hospital care and emergency medical services provider in the region, have jointly launched the $1 million Human

Continue Reading
CSP
1 min read
16

#24-379 Listing of Derivatives at NGM

November 6, 2024
0

Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market

Continue Reading
CSP
3 min read
20

BLA for pegzilarginase in the treatment of arginase 1 deficiency (ARG1-D) accepted for priority review by the U.S. FDA

November 6, 2024
0

Reading Time: 2 minutes Stockholm, November 5, 2024: Immedica announces today that the Biologics License Application (BLA) for pegzilarginase in the treatment of arginase 1 deficiency (ARG1-D) has been successfully validated and accepted for priority review by the U.S. Food and Drug Administration (FDA). Anders

Continue Reading
CSP
5 min read
16

Diamyd Medical and INNODIA partner for Type 1 Diabetes awareness and patient recruitment for the DIAGNODE-3 precision medicine trial

November 6, 2024
0

Reading Time: 3 minutes Diamyd Medical has entered a strategic partnership with INNODIA, an international non-profit organization dedicated to advancing research on disease modifying therapies for Type 1 Diabetes. The partnership will leverage INNODIA’s extensive EU-based clinical network with the aim to further amplify patient enrolment

Continue Reading